Comments
Amgen experimental drug lowers cholesterol in mid-stage trial
06.11.2012. | LOS ANGELES (Reuters) - Amgen Inc's experimental drug AMG145 reduced levels of bad cholesterol by as much as 55 percent in combination with statin drugs in patients genetically predisposed to high cholesterol, according to data from a midstage trial presented on Monday....
